Volume 67, Issue 3 pp. e71-e72
PLAIN LANGUAGE SUMMARY
Free Access

Differentiating non-epileptic seizures from epileptic seizures in Glut1 deficiency syndrome

First published: 03 January 2025

Glucose transporter type 1 deficiency syndrome (Glut1DS) is a neurological disorder caused by metabolic disturbances in the brain. Apart from epileptic seizures, various paroxysmal symptoms can occur as transient brain dysfunction triggered by energy deficits, often following prolonged fasting or exercise. Thus, Glut1DS presents with chronic neurological symptoms, including cognitive impairment, movement disorders (e.g. ataxia, spasticity, and dystonia), and both epileptic and non-epileptic seizures.

Non-epileptic seizures associated with Glut1DS are essentially situation-related events provoked and ameliorated by specific factors. As is true in other inborn errors of metabolism, misdiagnosis of these paroxysmal events as epileptic seizures may lead to an erroneous diagnosis of pharmaco-resistant epilepsy due to poor response to conventional antiseizure medications. This can result in unnecessary or inappropriate treatments.

This study highlights the importance of distinguishing non-epileptic seizures from epileptic seizures. Non-epileptic seizures can be categorized as follows:
  • Paroxysmal altered consciousness
  • Paroxysmal movement disorders (e.g. eye-head movements, ataxia, spasticity, weakness, and involuntary movements)
  • Paroxysmal dysaesthesia
  • Paroxysmal vomiting
Key features differentiating nonepileptic seizures from epileptic seizures include:
  • Absence of complete loss of consciousness
  • Absence of anterograde or retrograde amnesia
  • Rapid postictal recovery even after prolonged seizures
  • Serial or simultaneous occurrence of different seizure types or non-stereotyped presentations of the same seizure type
Non-epileptic seizures are often under-recognized but require different therapeutic approaches than epileptic seizures. Although ongoing epileptic seizures require prompt treatment with antiseizure medications, ongoing non-epileptic seizures should be managed as follows:
  1. Avoiding provoking factors.
  2. Providing rest and energy supplementation once seizures occur.
Awareness of the differentiation of non-epileptic seizures from epileptic seizures is critical for formulating preventive strategies and making therapeutic decisions, particularly for acute exacerbation seizures.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.